Roxagen is a first-in-class, oral HIF-PH inhibitor that helps stimulate erythropoiesis by increasing the body's production of erythropoietin (EPO), improving iron regulation, and overcoming the EPO-suppressive effects of inflammation on hemoglobin production and red blood cell synthesis by reducing hepcidin.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Roxagen is prescribed for adult patients with symptomatic anemia associated with chronic kidney disease (CKD).
Roxadustat is an orally bioavailable HIF-PH inhibitor with potential anti-anemic properties. It works by inhibiting the enzyme HIF-PH, which typically degrades HIF transcription factors under normal oxygen levels. Inhibiting HIF-PH prevents the breakdown of HIF, promoting increased erythropoietin production, enhancing erythropoiesis, and improving iron metabolism. Roxadustat reduces hepcidin levels, improving iron availability and increasing hemoglobin levels. It also helps regulate iron metabolism, increasing serum transferrin, iron absorption, and iron release, especially in CKD patients.
Roxadustat has been shown to effectively boost red blood cell count while keeping plasma erythropoietin levels within a normal range, without the need for intravenous iron supplementation.
Roxadustat is also known to significantly reduce cholesterol levels, regardless of the use of statins or other cholesterol-lowering drugs.
Roxadustat is taken orally three times a week, with a dose tailored to maintain hemoglobin (Hb) levels between 10-12 g/dL:
For patients not on erythropoiesis-stimulating agents:
For patients switching from erythropoiesis-stimulating agents:
Roxadustat is not recommended for patients with severe liver impairment.
Missed Dose: If there is more than 24 hours before the next dose, take the missed dose immediately. If less than 24 hours remain, skip the dose and take the next one on schedule. Do not take two doses on the same day.
Roxadustat should be taken orally with or without food. Take the medication as per the advice of a registered healthcare provider.
Increase or decrease the dose based on Hb levels using a stepwise adjustment (from 20 mg to 400 mg). Once adjusted, the dose should be maintained for at least 4 weeks. If Hb levels increase rapidly (>2.0 g/dL in 4 weeks), decrease the dose or suspend the medication immediately.
Overdosing may cause increased heart rate and elevated hemoglobin. Treatment may involve dose reduction or interruption. Roxadustat is not removed by dialysis.
Roxagen may interact with other medications, including:
Common side effects include hypertension, thrombosis (clots), diarrhea, peripheral edema, hyperkalemia, and nausea.
Roxadustat should not be used during pregnancy or breastfeeding.
Roxagen may increase the risk of thrombotic vascular events (TVEs) in patients with pre-existing risk factors. It should be used with caution in those with a history of seizures, liver disorders, or serious infections. Roxagen is not recommended for pregnant women.
Store below 30°C, in a dry place, away from light and moisture. Keep out of reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.